CN106191312B - A kind of quick multi-fluorescence immunoassay method and reagent for distinguishing AIV, NDV, MG and MS - Google Patents

A kind of quick multi-fluorescence immunoassay method and reagent for distinguishing AIV, NDV, MG and MS Download PDF

Info

Publication number
CN106191312B
CN106191312B CN201610573297.XA CN201610573297A CN106191312B CN 106191312 B CN106191312 B CN 106191312B CN 201610573297 A CN201610573297 A CN 201610573297A CN 106191312 B CN106191312 B CN 106191312B
Authority
CN
China
Prior art keywords
primer
fluorescence
seq
chicken
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610573297.XA
Other languages
Chinese (zh)
Other versions
CN106191312A (en
Inventor
郭鹏举
朱余军
丛峰
黄韧
陈梅丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Laboratory Animals Monitoring Institute
Original Assignee
Guangdong Laboratory Animals Monitoring Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Laboratory Animals Monitoring Institute filed Critical Guangdong Laboratory Animals Monitoring Institute
Priority to CN201610573297.XA priority Critical patent/CN106191312B/en
Publication of CN106191312A publication Critical patent/CN106191312A/en
Application granted granted Critical
Publication of CN106191312B publication Critical patent/CN106191312B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of quick multi-fluorescence immunoassay method and reagent for distinguishing avian influenza virus, newcastle disease virus, chicken virus mycoplasma and chicken Mycoplasma synoviae.The present invention is easy to operate, obtains target amplification fragment by PCR, is then hybridized amplified production, fluorescence-encoded micro-beads and Streptavidin phycoerythrin, then reads MFI values by detector, offer an explanation different types of cause of disease.The method of the present invention, at the same time can accurately detect avian influenza virus, newcastle disease virus, chicken virus mycoplasma and chicken Mycoplasma synoviae, and high specificity, high sensitivity are reproducible.Compared with traditional detection method, the method for the present invention is realized is carried out at the same time detection to a variety of different molecules of interest in same sample, and sample dosage is few, easy to operate, quick, can substantially reduce testing cost.The flexibility of the present invention is good, can add and subtract the species of detection cause of disease on this basis as needed.

Description

A kind of quick multi-fluorescence immunoassay method for distinguishing AIV, NDV, MG and MS and Reagent
Technical field
The invention belongs to the Pathogen test field of aquaculture, and in particular to a kind of quick differentiation bird flu(AIV), chicken new city Epidemic disease poison(NDV), chicken virus mycoplasma(MG)With chicken Mycoplasma synoviae(MS)Multi-fluorescence immunoassay method.
Background technology
As the demand of birds is on the increase in market, aviculture obtains swift and violent development, and aviculture intensive degree is not Disconnected to improve, the infection of fowl respiratory pathogens is in ascendant trend year by year.The breathing problem of fowl is always to cause the great warp of aviculture The principal element of Ji loss.The cause of disease of chicken respiratory tract disease has its complexity, it can have virus, mycoplasma and bacterium to cause hair Disease, clinically there is also various mixed infections.The generation of these diseases can not be ignored in poultry produces.The respiratory tract of chicken Disease often occurs, and the chicken of various ages in days, which can infect, even results in death, and Adult Chicken, which is laid eggs, to be declined, while the respiratory tract of chicken Disease incidence is high, easily causes the scabies secondary infection of a variety of diseases, such as mycoplasma to induce the gentle capsulitis of pneumonia of chicken, so Active prevention and timely treatment breathing problem have great meaning.
Avian influenza virus, newcastle disease virus, chicken virus mycoplasma and chicken Mycoplasma synoviae are important fowl respiratory diseases Original, clinical symptoms and pathological change are very much like, are difficult to distinguish in clinical and histopathology.Chicken respiratory tract disease is mostly mixed Infection is closed, clinically be easy to cause mistaken diagnosis, its antidiastole usually need to be by laboratory diagnostic technique, viral separation and mirror Fixed, serological test, enzyme-linked immunosorbent assay and diagnosis of molecular biology.Traditional detection method sensitiveness is low, specifically Property is poor, is not easy to detect mixed infection, and operating method is cumbersome, is unfavorable for the timely diagnoses and treatment of disease, causes great Economic loss.
With the fast development of molecular biology, multiplex PCR is widely used to the antidiastole of poultry diease mixed infection, its Principle is the multipair primer that design can amplify a variety of cause of disease specific fragment sizes to be measured at the same time, is added in PCR reaction systems Enter multipair primer, antidiastole can be carried out to a variety of cause of diseases.Multiple RT-PCR is simple because its sensitivity, specificity and operation Property is widely used in the mixing sense of poultry diease, but result judgement needs electrophoresis, time-consuming and laborious, and reaction product easily produces pollution And cause false positive, and multiplex PCR is distinguished by the size of fragment, has generally been arrived more than triple, clip size difference is big, The amplification efficiency of its every kind of cause of disease is different, and causing result, there are deviation.Fluorescent quantitative PCR technique has merged a variety of excellent of PCR Point, the change by directly detecting fluorescence signal in PCR reaction process, which is realized, quantifies molecules of interest, it is not necessary to which electrophoresis is examined Survey, and the complete stopped pipe type operation of whole process, pollution probability reduce, and avoid the false positive issue that Standard PCR is be easy to cause. Relatively conventional PCR, quantitative fluorescent PCR have advantage in sensitiveness, specificity and speed etc., but in practical applications, when When sample size is very big, substance fluorescent PCR is in cost and there is certain inferior position in terms of the time, and establishes a multi-fluorescence PCR method is more more complex than substance, its requirement higher to reagent and primer, while needs to ensure that different probe is marked Fluorophor between without interfering with each other, the fluorescence quantitative PCR instrument used has corresponding multiple sense channels, adds experiment difficulty Greatly.
The content of the invention
It is an object of the invention to provide it is a kind of quick distinguish avian influenza virus, newcastle disease virus, chicken virus mycoplasma and The reference of the multi-fluorescence immunoassay of chicken Mycoplasma synoviae.
The another purpose of the present invention is to provide a kind of quick differentiation avian influenza virus, newcastle disease virus, chicken virus mycoplasma With the reagent of the multi-fluorescence immunoassay of chicken Mycoplasma synoviae.
It is an object of the invention to provide it is a kind of quick distinguish avian influenza virus, newcastle disease virus, chicken virus mycoplasma and The method of the multi-fluorescence immunoassay of chicken Mycoplasma synoviae.
The technical solution used in the present invention is:
A kind of primer of the quick multi-fluorescence immunoassay for distinguishing AIV, NDV, MG and MS, the primer nucleotide sequences It is as follows:
Primer A1:5’-ATGAGTCTTCTACCCGAGG-3’(SEQ ID NO:1),
Primer A2:5’-TCAGAGGTGACAGGATTG-3’(SEQ ID NO:2);
Primer N1:5’-CTCATCTCAGACAGGGTCAATC-3’(SEQ ID NO:3),
Primer N2:5’-ATGGAGTCACCAAGGGG-3’(SEQ ID NO:4);
Primer G1:5’-CTTACAGATTACAGGAGCAG-3’(SEQ ID NO:5),
Primer G2:5’-AAGCATTTCATTTGTTTTAC-3’(SEQ ID NO:6);
Primer S1:5’-ATTAGCAGCTAGTGCAGTGG-3’(SEQ ID NO:7),
Primer S2:5’-TTTGAGGATTATCAGTATTTG-3’(SEQ ID NO:8).
Further, the 5 ' ends of described wherein one primer of primer A1 and A2 are biotinylated;
5 ' the ends of described wherein one primer of primer N1 and N2 are biotinylated;
5 ' the ends of described wherein one primer of primer G1 and G2 are biotinylated;
5 ' the ends of described wherein one primer of primer S1 and S2 are biotinylated.
Further, the 5 ' of the primer not being biotinylated in the primer A1 and A2, N1 and N2, G1 and G2, S1 and S2 End is connected with tag sequences, and the tag sequences can be with the anti-tag sequence complementary pairings that are carried in fluorescence-encoded micro-beads.
Further, the tag sequences connected in this 4 groups of primer pairs of the primer A1 and A2, N1 and N2, G1 and G2, S1 and S2 Column selection is from SEQ ID NO:Tag sequences shown in 9 ~ 12, and the tag sequences connected in 4 groups of primer pairs are different.
A kind of reagent of the quick multi-fluorescence immunoassay for distinguishing AIV, NDV, MG and MS, contains above-mentioned in the reagent One primer.
Further, also containing streptavidin-phycoerythrin compound, the different iridescent of 4 kinds of codings in mentioned reagent Fluorescence-encoded micro-beads.
Further, also containing the anti-tag sequences with tag sequences complementary pairing in primer in the fluorescence-encoded micro-beads Row, it is different to encode the anti-tag sequences contained in the fluorescence-encoded micro-beads of different iridescent.
A kind of method of the quick multi-fluorescence immunoassay for distinguishing AIV, NDV, MG and MS, includes the following steps:
1)Viral RNA or/and DNA are extracted from sample;
2)Using the viral RNA of extraction or/and DNA as template, RT-PCR amplifications are carried out with any of the above-described primer;
3)By upper step amplified production, the fluorescence-encoded micro-beads of the different iridescent of 4 kinds of codings, streptavidin-phycoerythrin Hybridized;
4)After hybridization, analysis is detected hybrid product by Luminex systems, determines the type of its cause of disease;
The above method is used for the diagnose and treat of non-disease.
Further, step 2)The reaction system of middle RT-PCR amplification is:
5×buffer 4µL
dNTP 0.8µL
2 μ L of primer mixed liquor
0.8 μ L of enzyme
1 μ L of template
ddH2O 11.4µL
Total 20µL;
Step 2)The response procedures of middle RT-PCR amplification are:50 DEG C of reverse transcription 30min;94 DEG C of pre-degeneration 15min;94 DEG C of changes Property 30s, 60 DEG C annealing 25s, 72 DEG C extension 20s;Circulation 35 times;72 DEG C extend 10min eventually.
Further, step 3)Described in the reaction system that hybridizes and program be:
4 kinds of 20 μ L of fluorescence-encoded micro-beads
75 μ L of streptavidin-phycoerythrin
5 μ L of amplified production
100 μ L of cumulative volume;37 DEG C of reaction 30min.
The beneficial effects of the invention are as follows:
1)The method of the present invention is at the same time to avian influenza virus, newcastle disease virus, chicken virus mycoplasma and chicken Mycoplasma synoviae When being detected, target amplification fragment is obtained by RT-PCR, it is then that amplified production, fluorescence-encoded micro-beads and strepto- is affine Element-phycoerythrin(SA-PE)Hybridized, when then reading MFI values by detector, offer an explanation different types of cause of disease.
2)The method of the present invention can be at the same time to avian influenza virus, newcastle disease virus, chicken virus mycoplasma and chicken bursa synovialis branch Substance is accurately detected, and high specificity, and high sensitivity is reproducible.Compared with traditional detection method, the method for the present invention Realize and detection is carried out at the same time to a variety of different molecules of interest in same sample, sample dosage is few, easy to operate, quick, can Substantially reduce testing cost.The present invention can guarantee that identical renaturation temperature and hybridization efficiency, and effectively avoid different testing sample mark Crisscrossing between the microballoon of note.
Brief description of the drawings
Fig. 1 is the four of avian influenza virus, newcastle disease virus, chicken virus mycoplasma and chicken Mycoplasma synoviae and manual simulation The electrophoretogram of the RT-PCR of double infection dye;
Fig. 2 is the four of avian influenza virus, newcastle disease virus, chicken virus mycoplasma and chicken Mycoplasma synoviae and manual simulation The multi-fluorescence immunoassay method test experience result figure of double infection dye;
Fig. 3 is that the multi-fluorescence of avian influenza virus, newcastle disease virus, chicken virus mycoplasma and chicken Mycoplasma synoviae is immunized Analysis method detects specificity experiments result figure;
Fig. 4 is that the multi-fluorescence of avian influenza virus, newcastle disease virus, chicken virus mycoplasma and chicken Mycoplasma synoviae is immunized Analysis method detection sensitivity experimental result picture;
Fig. 5 is that the multi-fluorescence of avian influenza virus, newcastle disease virus, chicken virus mycoplasma and chicken Mycoplasma synoviae is immunized Analysis method clinical detection experimental result picture.
Embodiment
A kind of primer of the quick multi-fluorescence immunoassay for distinguishing AIV, NDV, MG and MS, the primer nucleotide sequences It is as follows:
Primer A1:5’-ATGAGTCTTCTACCCGAGG-3’(SEQ ID NO:1),
Primer A2:5’-TCAGAGGTGACAGGATTG-3’(SEQ ID NO:2);
Primer N1:5’-CTCATCTCAGACAGGGTCAATC-3’(SEQ ID NO:3),
Primer N2:5’-ATGGAGTCACCAAGGGG-3’(SEQ ID NO:4);
Primer G1:5’-CTTACAGATTACAGGAGCAG-3’(SEQ ID NO:5),
Primer G2:5’-AAGCATTTCATTTGTTTTAC-3’(SEQ ID NO:6);
Primer S1:5’-ATTAGCAGCTAGTGCAGTGG-3’(SEQ ID NO:7),
Primer S2:5’-TTTGAGGATTATCAGTATTTG-3’(SEQ ID NO:8).
Preferably, the 5 ' ends of described wherein one primer of primer A1 and A2 are biotinylated;
5 ' the ends of described wherein one primer of primer N1 and N2 are biotinylated;
5 ' the ends of described wherein one primer of primer G1 and G2 are biotinylated;
5 ' the ends of described wherein one primer of primer S1 and S2 are biotinylated.
Preferably, 5 ' ends of the primer not being biotinylated in the primer A1 and A2, N1 and N2, G1 and G2, S1 and S2 It is connected with tag sequences, the tag sequences can be with the anti-tag sequence complementary pairings that are carried in fluorescence-encoded micro-beads.
Preferably, the tag sequences connected in this 4 groups of primer pairs of the primer A1 and A2, N1 and N2, G1 and G2, S1 and S2 Selected from SEQ ID NO:Tag sequences shown in 9 ~ 12, and the tag sequences connected in 4 groups of primer pairs are different.
A kind of reagent of the quick multi-fluorescence immunoassay for distinguishing AIV, NDV, MG and MS, contains above-mentioned in the reagent One primer.
Preferably, different iridescent also are encoded containing streptavidin-phycoerythrin compound, 4 kinds in mentioned reagent Fluorescence-encoded micro-beads.
Preferably, the anti-tag sequences with tag sequences complementary pairing in primer are also contained in the fluorescence-encoded micro-beads, It is different to encode the anti-tag sequences contained in the fluorescence-encoded micro-beads of different iridescent.
A kind of method of the quick multi-fluorescence immunoassay for distinguishing AIV, NDV, MG and MS, includes the following steps:
1)Viral RNA or/and DNA are extracted from sample;
2)Using the viral RNA of extraction or/and DNA as template, RT-PCR amplifications are carried out with any of the above-described primer;
3)By upper step amplified production, the fluorescence-encoded micro-beads of the different iridescent of 4 kinds of codings, streptavidin-phycoerythrin Hybridized;
4)After hybridization, analysis is detected hybrid product by Luminex systems, determines the type of its cause of disease;
The above method is used for the diagnose and treat of non-disease.
Preferably, step 2)The reaction system of middle RT-PCR amplification is:
5×buffer 4µL
dNTP 0.8µL
2 μ L of primer mixed liquor
0.8 μ L of enzyme
1 μ L of template
ddH2O 11.4µL
Total 20µL;
Step 2)The response procedures of middle RT-PCR amplification are:50 DEG C of reverse transcription 30min;94 DEG C of pre-degeneration 15min;94 DEG C of changes Property 30s, 60 DEG C annealing 25s, 72 DEG C extension 20s;Circulation 35 times;72 DEG C extend 10min eventually.
Preferably, step 3)Described in the reaction system that hybridizes and program be:
4 kinds of 20 μ L of fluorescence-encoded micro-beads
75 μ L of streptavidin-phycoerythrin
5 μ L of amplified production
100 μ L of cumulative volume;37 DEG C of reaction 30min.
Preferably, step 3)In 4 kinds of different iridescent of coding fluorescence-encoded micro-beads in also contain and tag sequences in primer The anti-tag sequences of complementary pairing, the anti-tag sequences contained in 4 kinds of fluorescence-encoded micro-beads are different.
With reference to specific embodiment, the present invention is further illustrated, but is not limited thereto.
1 primer of embodiment
After being screened to designed a large amount of primers, find primer pair A1 and A2, N1 and N2, G1 and G2, S1 and S2 pairs of fast detection bird flu at the same time(AIV), newcastle disease virus(NDV), chicken virus mycoplasma(MG)With chicken Mycoplasma synoviae (MS)Effect it is best, its base sequence is as follows.
Primer A1:5’-ATGAGTCTTCTACCCGAGG-3’(SEQ ID NO:1),
Primer A2:5’-TCAGAGGTGACAGGATTG-3’(SEQ ID NO:2);
Primer N1:5’-CTCATCTCAGACAGGGTCAATC-3’(SEQ ID NO:3),
Primer N2:5’-ATGGAGTCACCAAGGGG-3’(SEQ ID NO:4);
Primer G1:5’-CTTACAGATTACAGGAGCAG-3’(SEQ ID NO:5),
Primer G2:5’-AAGCATTTCATTTGTTTTAC-3’(SEQ ID NO:6);
Primer S1:5’-ATTAGCAGCTAGTGCAGTGG-3’(SEQ ID NO:7),
Primer S2:5’-TTTGAGGATTATCAGTATTTG-3’(SEQ ID NO:8).
The present invention distinguishes 4 kinds of AIV, NDV, MG and MS cause of diseases using the method for multi-fluorescence immunoassay, therefore will Above-mentioned primer makees further modification, to meet that corresponding operation requires.5 ' the ends of wherein primer A1, N1, G1 and S1 are connected with Tag sequences, the tag sequences connected are respectively:
The tag sequences of primer A1 are:5’-TACTACTTCTATAACTCACTTAAA-3’(SEQ ID NO:9);
The tag sequences of primer N1 are:5’-ACTTATTTCTTCACTACTATATCA-3’(SEQ ID NO:10);
The tag sequences of primer G1 are:5’-CACTACACATTTATCATAACAAAT-3’(SEQ ID NO:11);
The tag sequences of primer S1 are:5’-CTTTCTTAATACATTACAACATAC-3’(SEQ ID NO:12).
In addition, 5 ' the ends of primer A2, N2, G2 and S2 are also added with biotin labeling.
Embodiment 2 is used to quickly distinguish bird flu(AIV), newcastle disease virus(NDV), chicken virus mycoplasma(MG)And chicken Mycoplasma synoviae(MS)Multi-fluorescence immunological assay reagents
The reagent includes following components:
(1)The primer for multi-fluorescence immunoassay designed by embodiment 1;
(2)The fluorescence-encoded micro-beads for including anti-tag sequences of the different iridescent of 4 kinds of codings, the anti-tag sequences Row can correspondingly with the tag sequence complementary pairings in multi-fluorescence immunoassay primer;4 kinds of microballoons are purchased from luminex companies, Wherein the corresponding fluorescence-encoded micro-beads number of AIV, NDV, MS and MG for MTAG-A029, MTAG-A034, MTAG-A025 and MTAG-042。
(3)Streptavidin-phycoerythrin compound.
3 bird flu of embodiment(AIV), newcastle disease virus(NDV), chicken virus mycoplasma(MG)With chicken Mycoplasma synoviae (MS)Multi-fluorescence immunoassay method detection method foundation
(1)The structure of AIV, NDV, MG and MS plasmid
The RNA/DNA that instrument extracts AIV, NDV, MG, MS cause of disease respectively is extracted automatically with the nucleic acid of Tiangeng, respectively embodiment 1 Designed corresponding primer, carries out RT-PCR amplifications, amplified production is detected into row agarose gel electrophoresis respectively and cuts glue Purifying.It will be purified with the kit of TaKaRa companies, cDNA after purification is respectively connected in pMD-19T carriers, will be connected Product is converted to DH5a competent cells, selects monoclonal, carries out bacterium colony PCR identifications, and the bacterium colony for being accredited as positive bacteria is carried out Plasmid extraction, send sequencing.
(2)Plasmid PCR expands
Carry out substance, quadruple RT-PCR amplifications to AIV, NDV, MS, MG primer respectively with the primer described in embodiment 1.
The preparation of sense primer mixed liquor:By A1, N1, G1 and S1 with molar ratio 1:1:1:1 ratio is mixed;Draw in downstream The preparation of thing mixed liquor:By A2, N2, G2 and S2 with molar ratio 1:1:1:1 ratio is mixed.Utilize AIV, NDV, MS, MG 4 The specific template of kind cause of disease, and AIV, NDV, MS, MG quadruple template, the idiocrasy region viral to above-mentioned four kinds are expanded Increase.The wherein preparation of quadruple template:By four kinds of plasmids with volume ratio 1:1:1:1 ratio is mixed.
Pcr amplification reaction system is as follows:
The response procedures of amplification are:94 DEG C of pre-degeneration 5min;94 DEG C of denaturation 30s, 60 DEG C of annealing 25s, 72 DEG C of extension 20s; Circulation 35 times;72 DEG C extend 10min eventually.
Electrophoresis detection result:Above-mentioned PCR product is analyzed into row agarose gel electrophoresis, its electrophoretogram is as shown in Figure 1.1: PCR blank controls, M:DL2000bp DNA marker, 2:AIV, 3:MG, 4:MS, 5:NDV, 6:To AIV+NDV+MS+MG into Capable Quadruple- PCR.From figure 1 it appears that the amplified production size of AIV is about 186bp, the amplified production size of NDV is about The amplified production size of 155bp, MG are about 133bp, and the amplified production size of MS is about 141bp, due to these four viral expansions It is close to increase primer size, so the electrophoretic band of Quadruple- PCR amplified production can not be differentiated.
(3)By the PCR product of gained and fluorescence-encoded micro-beads working solution, Streptavidin phycoerythrin(SA-PE)Work Liquid hybridizes, and comprises the following steps:
Be coated with 4 kinds of microballoons of special anti-tag sequences respectively, wherein anti-tag sequences can correspondingly with AIV, Tag sequence complementary pairings on the viral primers of tetra- kinds of NDV, MS and MG.Four kinds of microballoons are purchased from luminex companies, specifically The corresponding fluorescence-encoded micro-beads number of AIV, NDV, MS and MG are MTAG-A029, MTAG-A034, MTAG-A025 and MTAG- A042。
The preparation of fluorescence-encoded micro-beads working solution:By 2500/μ l fluorescence-encoded micro-beads with 1.1 × Tm Hybrdization Buffer are diluted to 1 μ l and about contain 125/kind fluorescence-encoded micro-beads.
It is prepared by SA-PE working solutions:1mg/ml SA-PE are diluted to 10 μ g/ μ with 1 × Tm Hybrdization Buffer l。
Fluorescence-encoded micro-beads working solution is fully resuspended, each sample well and background hole add 20 μ l of microballoon working solution, sample 5 μ l PCR products are added in hole, 5 μ l PCR blank products are added in background hole, the SA-PE working solutions of 75 μ l is added, fills Divide and mix, 37 DEG C of incubation 30min in metal heater.
The 50 above-mentioned reaction solutions of μ l after hybridization are detected by the explanation according to 200 instruments of detector Luminex, as a result As shown in Fig. 2, " AIV+NDV+MS+MG " represents Quadruple- PCR result in figure;" AIV ", " NDV ", " MS ", " MG " respectively to AIV, The substance PCR that NDV, MS and MG are carried out;From figure 2 it can be seen that although the amplified production of quadruple template can not be differentiated with electrophoresis, But when reading MFI values with 200 instruments of detector Luminex, hence it is evident that offer an explanation different types of cause of disease.
As a result criterion(Note:The criterion is only for reference, and also result criterion can be adjusted)It is as follows:
Lowest detection threshold value(Cutoff values)Determine:Choose 10 healthy chicken tissue samples(The parallel repetition 3 of each sample It is secondary), MFI values are read respectively and calculate its average value and standard deviation.Using the MFI values of average value plus 3 times of standard deviations set its as Cutoff values.It is 450.8 that the present invention, which obtains cutoff values, therefore the cutoff values of the present invention are set to 500.Only detect sample When the MFI values of product are higher than 500, which could effectively be analyzed.
The analysis of sample to be tested judges:1)As the MFI value > 500 of sample to be tested, it is judged as positive sample;2)Treat test sample During this MFI values≤500, it is judged as negative, it is necessary to carry out repeatedly experiment or take other detection methods further to verify.
The multi-fluorescence immunoassay detection specificity experiments of embodiment 4 AIV, NDV, MS and MG
Respectively with avian influenza virus, newcastle disease virus, chicken Mycoplasma synoviae, chicken virus mycoplasma, chicken infectivity throat gas Pipe inflammation virus, avian infectious bronchitis virus, avian infectious anemia virus, Marek's disease poison carry out multi-fluorescence as template Immunoassay detects.Experimental result is as shown in figure 3, only avian influenza virus, newcastle disease virus, Mycoplasma synoviae, chicken are malicious Mycoplasma is the positive, and others are feminine gender, illustrates that detection architecture specificity is good.
Embodiment 5:The multi-fluorescence immunoassay detection sensitivity experiment of AIV, NDV, MS and MG
The plasmid of preparation is quantified, is diluted using 10 times of dilution methods, is diluted to 101Copies/ μ l, use are above-mentioned The multi-fluorescence immunoassay method of foundation is detected.The multi-fluorescence immunoassay detection sensitivity of AIV, NDV, MS and MG Experimental result as shown in figure 4, test result indicates that, the sensitivity of all cause of diseases detection is limited to 102copies/µl。
Embodiment 6:The detection of sample
From the larynx tracheae of chicken house collection, lung, kidney, liver sample, instrument extraction RNA/DNA is extracted automatically with Tiangeng nucleic acid, is used The RT-PCR kit of Qiagen are expanded, using RNA/DNA as template, using the multi-fluorescence of above-mentioned AIV, NDV, MS, MG Immunoassay detection method is detected, and amplified production hybridizes with fluorescence-encoded micro-beads and SA-PE, is detected in Luminex 200 Reading on instrument.For specific steps with reference to embodiment 3, experimental result is as shown in Figure 5.
Through regular-PCR test experience, the result shows that, sample 1,4,6,7,10,11,12,13,17,18,19,20,21 is the moon Property sample;5th, 9,14 be avian influenza virus sample;10 be newcastle disease virus sample;2nd, 8 be Mycoplasma synoviae sample;3、 15th, 16 be chicken virus mycoplasma sample.By sequencing analysis, as a result unanimously.
Above-described embodiment is the preferable embodiment of the present invention, but embodiments of the present invention and from above-described embodiment Limitation, other any Spirit Essences without departing from the present invention with made under principle change, modification, replacement, combine, simplification, Equivalent substitute mode is should be, is included within protection scope of the present invention.
<110>Experimental Animals Supervising Station, Guangdong Prov.
<120>A kind of quick multi-fluorescence immunoassay method and reagent for distinguishing AIV, NDV, MG and MS
<130>
<160> 12
<170> PatentIn version 3.5
<210> 1
<211> 19
<212> DNA
<213>Artificial sequence
<400> 1
atgagtcttc tacccgagg 19
<210> 2
<211> 18
<212> DNA
<213>Artificial sequence
<400> 2
tcagaggtga caggattg 18
<210> 3
<211> 22
<212> DNA
<213>Artificial sequence
<400> 3
ctcatctcag acagggtcaa tc 22
<210> 4
<211> 17
<212> DNA
<213>Artificial sequence
<400> 4
atggagtcac caagggg 17
<210> 5
<211> 20
<212> DNA
<213>Artificial sequence
<400> 5
cttacagatt acaggagcag 20
<210> 6
<211> 20
<212> DNA
<213>Artificial sequence
<400> 6
aagcatttca tttgttttac 20
<210> 7
<211> 20
<212> DNA
<213>Artificial sequence
<400> 7
attagcagct agtgcagtgg 20
<210> 8
<211> 21
<212> DNA
<213>Artificial sequence
<400> 8
tttgaggatt atcagtattt g 21
<210> 9
<211> 24
<212> DNA
<213>Artificial sequence
<400> 9
tactacttct ataactcact taaa 24
<210> 10
<211> 24
<212> DNA
<213>Artificial sequence
<400> 10
acttatttct tcactactat atca 24
<210> 11
<211> 24
<212> DNA
<213>Artificial sequence
<400> 11
cactacacat ttatcataac aaat 24
<210> 12
<211> 24
<212> DNA
<213>Artificial sequence
<400> 12
ctttcttaat acattacaac atac 24

Claims (9)

1. a kind of primer of the quick multi-fluorescence immunoassay for distinguishing AIV, NDV, MG and MS, the primer nucleotide sequences are such as Shown in lower:
Primer A1:5’-ATGAGTCTTCTACCCGAGG-3’(SEQ ID NO:1),
Primer A2:5’-TCAGAGGTGACAGGATTG-3’(SEQ ID NO:2);
Primer N1:5’-CTCATCTCAGACAGGGTCAATC-3’(SEQ ID NO:3),
Primer N2:5’-ATGGAGTCACCAAGGGG-3’(SEQ ID NO:4);
Primer G1:5’-CTTACAGATTACAGGAGCAG-3’(SEQ ID NO:5),
Primer G2:5’-AAGCATTTCATTTGTTTTAC-3’(SEQ ID NO:6);
Primer S1:5’-ATTAGCAGCTAGTGCAGTGG-3’(SEQ ID NO:7),
Primer S2:5’-TTTGAGGATTATCAGTATTTG-3’(SEQ ID NO:8);
The tag sequences connected in this 4 groups of primer pairs of the primer A1 and A2, N1 and N2, G1 and G2, S1 and S2 are selected from SEQ ID NO:Tag sequences shown in 9~12, and the tag sequences connected in 4 groups of primer pairs are different.
2. primer according to claim 1, it is characterised in that:
5 ' the ends of described wherein one primer of primer A1 and A2 are biotinylated;
5 ' the ends of described wherein one primer of primer N1 and N2 are biotinylated;
5 ' the ends of described wherein one primer of primer G1 and G2 are biotinylated;
5 ' the ends of described wherein one primer of primer S1 and S2 are biotinylated.
3. the primer according to profit requires 1, it is characterised in that in the primer A1 and A2, N1 and N2, G1 and G2, S1 and S2 5 ' ends of the primer not being biotinylated are connected with tag sequences, and the tag sequences can be with carrying in fluorescence-encoded micro-beads Anti-tag sequence complementary pairings.
4. a kind of reagent of the quick multi-fluorescence immunoassay for distinguishing AIV, NDV, MG and MS, it is characterised in that in the reagent Contain any primer of claims 1 to 3.
5. reagent according to claim 4, it is characterised in that also answered in the reagent containing streptavidin-phycoerythrin The fluorescence-encoded micro-beads of compound, the different iridescent of 4 kinds of codings.
6. reagent according to claim 4, it is characterised in that also contain and tag in primer in the fluorescence-encoded micro-beads The anti-tag sequences of sequence complementary pairing, it is mutual to encode the anti-tag sequences contained in the fluorescence-encoded micro-beads of different iridescent Differ.
A kind of 7. method of the quick multi-fluorescence immunoassay for distinguishing AIV, NDV, MG and MS, it is characterised in that including as follows Step:
1) viral RNA or/and DNA are extracted from sample;
2) using the viral RNA of extraction or/and DNA as template, RT-PCR expansions are carried out with any primer of claims 1 to 3 Increase;
3) upper step amplified production, the fluorescence-encoded micro-beads of the different iridescent of 4 kinds of codings, streptavidin-phycoerythrin are carried out Hybridization;
4) after hybridizing, analysis is detected hybrid product by Luminex systems, determines the type of its cause of disease;It is above-mentioned Method is used for the diagnose and treat of non-disease.
8. according to the method described in claim 7, it is characterized in that:The reaction system of RT-PCR amplifications is in step 2):
The response procedures of RT-PCR amplifications are in step 2):50 DEG C of reverse transcription 30min;94 DEG C of pre-degeneration 15min;94 DEG C of denaturation 30s, 60 DEG C of annealing 25s, 72 DEG C of extension 20s;Circulation 35 times;72 DEG C extend 10min eventually.
9. according to the method described in claim 7, it is characterized in that:The reaction system and program hybridized described in step 3) be:
CN201610573297.XA 2016-07-19 2016-07-19 A kind of quick multi-fluorescence immunoassay method and reagent for distinguishing AIV, NDV, MG and MS Active CN106191312B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610573297.XA CN106191312B (en) 2016-07-19 2016-07-19 A kind of quick multi-fluorescence immunoassay method and reagent for distinguishing AIV, NDV, MG and MS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610573297.XA CN106191312B (en) 2016-07-19 2016-07-19 A kind of quick multi-fluorescence immunoassay method and reagent for distinguishing AIV, NDV, MG and MS

Publications (2)

Publication Number Publication Date
CN106191312A CN106191312A (en) 2016-12-07
CN106191312B true CN106191312B (en) 2018-05-04

Family

ID=57494627

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610573297.XA Active CN106191312B (en) 2016-07-19 2016-07-19 A kind of quick multi-fluorescence immunoassay method and reagent for distinguishing AIV, NDV, MG and MS

Country Status (1)

Country Link
CN (1) CN106191312B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109706229A (en) * 2019-02-26 2019-05-03 南京天邦生物科技有限公司 The measuring method of chicken Mycoplasma synoviae culture solution potency

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104531901A (en) * 2014-12-31 2015-04-22 四川圣迪乐村生态食品股份有限公司 PCR detection method for detecting four kinds of poultry respiratory disease pathogens simultaneously
CN105671204A (en) * 2016-03-15 2016-06-15 山东省动物疫病预防与控制中心 Newcastle disease virus/avian influenza virus H9 subtype/infectious bronchitis virus triplex fluorescence quantification detection reagent and detection method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105154589B (en) * 2015-09-18 2018-07-06 广东省实验动物监测所 A kind of multi-fluorescence immunoassay method of quick differentiation PEDV, TGEV, PoRV

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104531901A (en) * 2014-12-31 2015-04-22 四川圣迪乐村生态食品股份有限公司 PCR detection method for detecting four kinds of poultry respiratory disease pathogens simultaneously
CN105671204A (en) * 2016-03-15 2016-06-15 山东省动物疫病预防与控制中心 Newcastle disease virus/avian influenza virus H9 subtype/infectious bronchitis virus triplex fluorescence quantification detection reagent and detection method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
应用复合RT-PCR 诊断禽支原体与其他呼吸道病原的混合感染;张秀美等;《中国预防兽医学报》;20030531;第25卷(第3期);第232-234页,尤其是第232页摘要,第232-233页第1.4节 *

Also Published As

Publication number Publication date
CN106191312A (en) 2016-12-07

Similar Documents

Publication Publication Date Title
CN105154589B (en) A kind of multi-fluorescence immunoassay method of quick differentiation PEDV, TGEV, PoRV
CN111500771B (en) Primer group and kit for detecting novel coronavirus SARS-CoV-2
CN110551846A (en) cpf1 kit for quickly detecting African swine fever virus nucleic acid and detection method thereof
CN106282416B (en) A kind of the multi-fluorescence immunoassay primer, kit and method of 5 kinds of fowl immunosupress cause of diseases of quick differentiation
CN106191311B (en) A kind of multiple liquid phase genetic chip method and reagent of quick detection cavy LCMV, SV, PVM, Reo-3 virus
CN106282417B (en) A kind of quick multi-fluorescence immunoassay primer, kit and method for distinguishing CAV, MDV, REV, IBDV
CN106011313B (en) A kind of the multi-fluorescence immunoassay method and reagent of quick differentiation ILTV, IBV, MG and MS
CN110484655A (en) The detection method of two generation of parainfluenza virus full-length genome sequencing
CN107574262A (en) A kind of fluorescence RT RAA primers, probe and detection method for being used to detect A (H 1 N 1) virus
CN103210093B (en) Method for detecting digestive tract pathogens
CN106191319B (en) A kind of multi-fluorescence immunoassay method of 6 kinds of fowl respiratory pathogens of quick differentiation
CN103276099B (en) Primer and kit for fluorescent quatititive PCR (polymerase chain reaction) detection of helicobacter pylori
CN106222256A (en) A kind of Multiple immunizations fluorescence analysis method detecting chicken virus mycoplasma and chicken Mycoplasma synoviae
CN106086241B (en) A kind of primer, kit and the method for the multi-fluorescence immunoassay of 4 kinds of fowl respiratory pathogens of quick differentiation
CN106191312B (en) A kind of quick multi-fluorescence immunoassay method and reagent for distinguishing AIV, NDV, MG and MS
CN105603081B (en) Non-diagnosis-purpose qualitative and quantitative detection method for intestinal microorganisms
CN107326098A (en) The multi-fluorescence immunoassay method and reagent of a kind of quick differentiation Rabbit pest virus, sendai virus and lapine rotavirus
CN111471802A (en) Porcine delta coronavirus rapid detection primer, kit and application thereof
CN106319091B (en) The multi-fluorescence immunoassay method and kit of a kind of quick differentiation canine distemper virus, canine parvovirus and rabies viruses
CN112410465A (en) Novel coronavirus SARS-CoV-2ORF1ab and N gene constant temperature amplification primer group and kit
CN106544447B (en) A kind of Multiple immunizations fluorescence analysis primer, kit and method for detecting chicken Marek&#39;s disease virus and chicken infectious anemia virus
CN114836580B (en) Multiplex qPCR detection primer combination for respiratory tract infectious disease pathogens
CN102851395B (en) Liquid-phase chip method used for detecting infectious laryngotracheitis virus
CN106755600A (en) A kind of PCR kit for fluorescence quantitative for detecting Zaire type Ebola virus
CN111440902A (en) Porcine epidemic diarrhea virus detection primer, kit and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant